Private investment group Venturecraft has launched its second investment fund, Venturecraft Two, a S$50 million (US$36.8 million) fund aimed at medtech startups that are looking to expand in Asia.
It has been appointed a sector-specific accelerator by Spring Singapore for the medtech industry. This means that Spring Seeds Capital will co-invest in medtech companies with Venturecraft.
Each investment will be typically between S$500,000 and S$10million.
Venturecraft One, which was S$4million and launched last year, invested in a number of companies including AIM Biotech and Glissade Dental.